Medtronic Inc. (MDT): Today's Featured Health Services Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Medtronic ( MDT) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day up 0.4%. By the end of trading, Medtronic fell $0.62 (-1.2%) to $52.81 on average volume. Throughout the day, 3,579,639 shares of Medtronic exchanged hands as compared to its average daily volume of 4,562,100 shares. The stock ranged in price between $52.76-$53.48 after having opened the day at $53.46 as compared to the previous trading day's close of $53.43. Other companies within the Health Services industry that declined today were: Abiomed ( ABMD), down 7.4%, Baxter International ( BAX), down 6.4%, Spherix ( SPEX), down 5.7% and Navidea Biopharmaceuticals ( NAVB), down 5.6%.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. The company operates in two segments, Cardiac and Vascular Group, and Restorative Therapies Group. Medtronic has a market cap of $53.6 billion and is part of the health care sector. Shares are up 31.1% year to date as of the close of trading on Tuesday. Currently there are 6 analysts that rate Medtronic a buy, no analysts rate it a sell, and 12 rate it a hold.

TheStreet Ratings rates Medtronic as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, increase in net income and reasonable valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the positive front, MAKO Surgical Corporation ( MAKO), up 82.2%, Hansen Medical ( HNSN), up 14.9%, BioScrip ( BIOS), up 8.5% and Stereotaxis ( STXS), up 8.2% , were all gainers within the health services industry with Express Scripts ( ESRX) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Dow Rises for First Time in 9 Days, Oil Jumps as OPEC Agrees to Boost Output

Dow Rises for First Time in 9 Days, Oil Jumps as OPEC Agrees to Boost Output

German Automakers Slump After Trump Tweets New Tariff Threat

German Automakers Slump After Trump Tweets New Tariff Threat

Chipotle Rises After Wedbush Lifts Price Target

Chipotle Rises After Wedbush Lifts Price Target

Crude Rises on OPEC Deal That Doesn't Specify Output Boost

Crude Rises on OPEC Deal That Doesn't Specify Output Boost

Video: Stock Investors Shouldn't Fret About Oil Prices in the $60s

Video: Stock Investors Shouldn't Fret About Oil Prices in the $60s